Cargando…
A bcl-2 transgene expressed in hepatocytes protects mice from fulminant liver destruction but not from rapid death induced by anti-Fas antibody injection
Stimulation of the Fas (APO-1, CD95) receptor, which is present on a variety of cells, usually triggers a process of programmed cell death. Systemic injection of anti-Fas antibody into mice leads to fulminant liver destruction resulting from massive hepatocyte apoptosis, and to rapid death. Hepatocy...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1996
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2192310/ https://www.ncbi.nlm.nih.gov/pubmed/8642244 |
Ejemplares similares
-
RIPK1 protects hepatocytes from death in Fas-induced hepatitis
por: Filliol, Aveline, et al.
Publicado: (2017) -
Systemic injection of a tripeptide inhibits the intracellular activation of CPP32-like proteases in vivo and fully protects mice against Fas-mediated fulminant liver destruction and death
Publicado: (1996) -
Hepatocyte Bcl-3 protects from death-receptor mediated apoptosis and subsequent acute liver failure
por: Gehrke, Nadine, et al.
Publicado: (2022) -
Hepatitis B Virus Alters the Antioxidant System in Transgenic Mice and Sensitizes Hepatocytes to Fas Signaling
por: Wang, Qian, et al.
Publicado: (2012) -
CD40 Activation Induces Apoptosis in Cultured Human Hepatocytes via Induction of Cell Surface Fas Ligand Expression and Amplifies Fas-mediated Hepatocyte Death during Allograft Rejection
por: Afford, Simon C., et al.
Publicado: (1999)